Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

ISPE Singapore Affiliate Conference & Exhibition
23 - 25 August 2023
Times are shown in your local time zone GMT

ISPE Singapore 2023

Call for Papers

Uploaded Image

Call for Papers 2023


While the global pharmaceutical industry undergoes radical changes, the pandemic has underlined the importance of a strong, innovative ecosystem to address major health challenges. With advancements in technology and policy initiatives, the pharmaceutical manufacturing landscape is further transforming.

The Singapore affiliate Annual Conference draws pharmaceutical and biopharmaceutical professionals from all levels – whether students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2023 ISPE Singapore Annual Conference to learn and share progress, success stories, best practices and lessons learned.

Submit Proposal



Call for Proposals Timeline


1 December 2022
Call for Papers Open

28 February 2023
Submission Deadline

14 March 2023
Accepted Submitters Notified

Requested Submission Topics

The 2023 Singapore Annual Conference Programme Committee welcomes proposals aligning with the following content areas:

The Digital Transformation Journey is one of the most important strategic challenges in today’s pharma organisations. The maturity of the Business Processes and the Pharmaceutical Quality System are prerequisites for moving into digital operations. Digital transformation is a holistic approach to move from paper to electronic workflow-based end-to-end operations along the value chain. Key challenges of the transformation include: Integration, cultural change, data availability, and strategic ownership based on practical case studies.

With ISPE’s GAMP 5 2nd Edition providing a substantial amount of new and updated content, we welcome insights into: Computer Software Assurance, Data Integrity, Artificial Intelligence and Agile Software Development

Good Engineering Practice (GEP) is combination of standards, specifications, codes, regulatory and industrial guidelines as well as accepted engineering and design methods intended to design, construct, operate, and maintain pharmaceutical and/or biotechnology facilities that encompass regulatory compliance, safety, economics, environmental protection and operability. This focus area will be inspecting the transformation of engineering and project delivery in a digitalised world.

Applying harmonised approaches to innovative design solutions and project delivery strategies to ensure quality therapeutic products are brought to market in an efficient manner. Submissions addressing these topics may include: Digitalised & Aseptic case studies and presentations on the digital applications of aseptic requirements such as contamination control strategies, aseptic GMP requirements, etc.; Fully Contained—closed systems case studies and technologies and their use in pharmaceutical manufacturing, and the role of Contract Manufacturing in repatriation of API and medicines production.

The impact and potential utilisation of new technologies, processes, and disruptions on operations and logistics of the production of all types of therapies. Submissions may address supply chain shortages; the conditions that would encourage pharmaceutical manufacturing across Asia, and the requirements for capabilities and skillsets needed for the workforce of the future.

Regulatory and quality challenges, learnings, and opportunities which might include the current speed to market expectations, pandemic management, drug shortages, and the regulatory focus on data integrity.

Emerging and evolving technologies and practices that are helping drive a revolution in medicinal therapies, analytical techniques, manufacturing paradigms, medical devices including novel methods to deliver the next generation of drugs to patients.

Proposal Submission Types


Presentation
  • 20-minute presentation, to be considered as part of a track by the Programme Committee. Presentation should focus on new and innovative trends, a specific real-world strategy or campaign, case study/use case, a “how-to" presentation intended to help attendees gain a better understanding of the initiative and best practices that can be applied to day-to-day objectives or overall mission.
  • A 5-minute Q&A session follows the presentation.

Panel Discussion
  • 45-minute Panel Discussions enable the Moderator and panellists to focus in-depth on emerging trends, with audience participation via polls, questions and comments.

Workshop
  • Held concurrently with the main conference, deep-dive 1 hour sessions allow for key topics to be presented in detail. Formats may include interactive polls, case studies, practical exercises, demonstrations, videos etc to support presentations and discussions.

Proposal Guidelines


  • Proposals from/including pharma/bio-manufacturing speaker will be given priority over consulting firms/ vendor/suppliers.
  • All presentations must be free of commercial intent. Incomplete proposals will not be considered.
  • Presentations may comprise maximum 2 speakers, Workshops may comprise multiple speakers appropriate to the format.
  • By submitting a proposal, you acknowledge that, if your proposal is accepted, the speaker will attend/present in-person at the event and the speaker’s attendance at the event will be supported by their organisation.
  • Accepted speakers are responsible for their own travel and accommodation.
  • All accepted speakers will automatically be registered and receive complimentary conference registration.
  • Presentations must be submitted prior to the event and topic/content will be reviewed and apply the ISPE Singapore master slides format.